Casein Peptide Teat Seal for Bovine Mastitis Prevention
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for bovine mastitis, such as antimicrobial agents, often lead to bacterial resistance and do not effectively address the underlying issues of mammary gland infections, and there is a need for improved measures to prevent and treat mastitis in dairy cattle.
Innovation Solution
A therapeutic combination comprising casein proteins or casein-derived peptides, including β-casein, αS1-casein, αS2-casein, or K-casein, administered with a teat seal composition forming a physical barrier, which can be a dip, hydrogel, or biofilm, containing non-toxic heavy metal salts like bismuth, titanium, or zinc, to prevent and treat mastitis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antimicrobial agents are used to treat mastitis, then bacterial infection is addressed, but bacterial resistance develops and underlying issues are not resolved
Solution Approach 1:
The patent extracts and removes harmful antimicrobial agents from the treatment approach, replacing them with casein-derived peptides and teat seal compositions that physically and biologically prevent bacterial infection without promoting resistance. The solution takes out the problematic element (antimicrobials) and replaces it with natural, non-resistant-inducing alternatives.
Solution Approach 2:
The teat seal composition is applied in advance to create a physical barrier before bacterial infection occurs. The casein-derived peptides are administered preliminarily to modulate the mammary gland environment, preventing infection rather than treating it after onset, thereby eliminating the need for antimicrobials that cause resistance.
2Reliability
If teat seal composition with heavy metal salts is used, then physical barrier is formed to prevent infection, but metal residues may accumulate in milk
Solution Approach 1:
The patent changes the concentration and composition parameters of the teat seal formulation, using low concentrations of non-toxic heavy metal salts (bismuth, titanium, zinc) combined with casein-derived peptides. This parameter modification reduces metal residue accumulation while maintaining the physical barrier function for mastitis prevention.
Solution Approach 2:
Casein-derived peptides act as an intermediary substance that facilitates the formation and stability of the teat seal barrier while controlling metal salt deposition. The peptides mediate between the heavy metal salts and the mammary gland tissue, ensuring barrier formation without excessive metal accumulation in milk.
3Reliability
If casein proteins or peptides are administered, then mammary gland function is improved, but formulation complexity increases
Solution Approach 1:
The patent merges casein-derived peptides and teat seal compositions into a unified therapeutic combination that can be administered together. This combination approach consolidates multiple functions (mammary gland modulation and physical barrier formation) into a single treatment protocol, reducing overall complexity despite the multi-component nature of the formulation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The combination effectively reduces mastitis symptoms, improves milk hygiene, and increases milk yield without worsening milk quality, while also reducing metal residues in milk, thus addressing the limitations of existing treatments.
Implementation Method 1
the teat seal composition forms a physical barrier on a teat surface, in a teat canal, or in a teat cistern of an animal
Implementation Method 2
the teat seal composition comprises a heavy metal, or salt thereof. In certain embodiments, the teat seal composition comprises a non-toxic heavy metal salt. In certain embodiments, the non-toxic heavy metal salt is selected from the group consisting of bismuth salt, titanium salt, zinc salt, barium salt, and any combination thereof
Implementation Method 3
a composition comprising at least one casein protein or casein-derived peptide
Implementation Method 4
Casein-derived peptides were previously reported in the treatment of mammary gland infection
Data Source
AI summary
The present disclosure provides compositions and methods for modulating various mammary' disorders and conditions. The disclosure further provides a therapeutic combination of a composition of at least one casein protein or casein-derived peptide; and a teat seal composition.